World's Best Scientists 2026 revealed!

D-Index & Metrics

Microbiology

D-Index
54
Citations
13871
World Ranking
3919
National Ranking
349

Overview

Andreas Wack is affiliated with The Francis Crick Institute in the United Kingdom. Their research primarily spans fields related to Medicine, Immunology and Microbiology, with significant contributions in Immunology, Infectious Diseases, Epidemiology, Pulmonary and Respiratory Medicine, and Molecular Biology.

The main topics of their work focus on SARS-CoV-2 and COVID-19 Research, COVID-19 Clinical Research Studies, interferon and immune responses, Respiratory viral infections research, Long-Term Effects of COVID-19, T-cell and B-cell Immunology, and Immune Response and Inflammation.

Frequent publication venues for Andreas Wack include bioRxiv (Cold Spring Harbor Laboratory), The Journal of Experimental Medicine, Science Immunology, Nature Immunology, and Cell. These venues represent platforms where they have disseminated their research findings.

Recent papers authored or co-authored by Andreas Wack include the following:

  • Type I and III interferons disrupt lung epithelial repair during recovery from viral infection (2020, Science)
  • Influenza-induced monocyte-derived alveolar macrophages confer prolonged antibacterial protection (2020, Nature Immunology)
  • The interferon landscape along the respiratory tract impacts the severity of COVID-19 (2021, Cell)
  • Host-directed immunotherapy of viral and bacterial infections: past, present and future (2022, Nature reviews. Immunology)
  • COVID-19 and emerging viral infections: The case for interferon lambda (2020, The Journal of Experimental Medicine)

Andreas Wack has frequently collaborated with several co-authors in their research projects. These include Stefania Crotta, Jack Major, Miriam Llorian, Katja Finsterbusch, and Rupert Beale.

Best Publications

  • Type I interferons in infectious disease.

    Finlay McNab;Katrin Mayer-Barber;Alan Sher;Andreas Wack

  • Inhibition of Natural Killer Cells through Engagement of CD81 by the Major Hepatitis C Virus Envelope Protein

    Stefania Crotta;Annalisa Stilla;Andreas Wack;Annalisa D'Andrea

  • Type I and III interferons disrupt lung epithelial repair during recovery from viral infection.

    Jack Major;Stefania Crotta;Miriam Llorian;Teresa M. McCabe

  • The Adjuvants Aluminum Hydroxide and MF59 Induce Monocyte and Granulocyte Chemoattractants and Enhance Monocyte Differentiation toward Dendritic Cells

    Anja Seubert;Elisabetta Monaci;Mariagrazia Pizza;Derek T. O’Hagan

  • Vaccine adjuvants alum and MF59 induce rapid recruitment of neutrophils and monocytes that participate in antigen transport to draining lymph nodes.

    Samuele Calabro;Marco Tortoli;Barbara C. Baudner;Alessandra Pacitto

  • Guarding the frontiers: the biology of type III interferons

    Andreas Wack;Ewa Terczyńska-Dyla;Rune Hartmann

  • Pathogenic potential of interferon αβ in acute influenza infection

    Sophia Davidson;Stefania Crotta;Teresa M McCabe;Andreas Wack

  • Influenza-induced monocyte-derived alveolar macrophages confer prolonged antibacterial protection.

    Helena Aegerter;Justina Kulikauskaite;Stefania Crotta;Harshil Patel

  • Microbiota-Driven Tonic Interferon Signals in Lung Stromal Cells Protect from Influenza Virus Infection.

    Konrad C. Bradley;Katja Finsterbusch;Daniel Schnepf;Stefania Crotta

  • Type I and Type III Interferons Drive Redundant Amplification Loops to Induce a Transcriptional Signature in Influenza-Infected Airway Epithelia

    Stefania Crotta;Sophia Davidson;Tanel Mahlakoiv;Christophe J. Desmet

  • Host-directed immunotherapy of viral and bacterial infections: past, present and future

    Unknown

  • Safety of MF59 adjuvant.

    Viola Schultze;Vicente D’Agosto;Andreas Wack;Deborah Novicki

  • Functional specialization of human circulating CD16 and CD1c myeloid dendritic-cell subsets

    Diego Piccioli;Simona Tavarini;Erica Borgogni;Veronica Steri

  • The interferon landscape along the respiratory tract impacts the severity of COVID-19.

    Benedetta Sposito;Achille Broggi;Laura Pandolfi;Stefania Crotta

  • IFNλ is a potent anti‐influenza therapeutic without the inflammatory side effects of IFNα treatment

    Sophia Davidson;Teresa M McCabe;Stefania Crotta;Hans Henrik Gad

  • Disease-promoting effects of type I interferons in viral, bacterial, and coinfections.

    Sophia Davidson;Mala K. Maini;Andreas Wack

  • Pandemic peak SARS-CoV-2 infection and seroconversion rates in London frontline health-care workers.

    Catherine F Houlihan;Nina Vora;Thomas Byrne;Dan Lewer

  • COVID-19 and emerging viral infections: The case for interferon lambda.

    Ludmila Prokunina-Olsson;Noémie Alphonse;Noémie Alphonse;Ruth E. Dickenson;Joan E. Durbin

  • Combination adjuvants for the induction of potent, long-lasting antibody and T-cell responses to influenza vaccine in mice.

    Andreas Wack;Barbara C. Baudner;Anne K. Hilbert;Ilaria Manini

  • Adjuvanticity of the oil-in-water emulsion MF59 is independent of Nlrp3 inflammasome but requires the adaptor protein MyD88

    Anja Seubert;Samuele Calabro;Laura Santini;Barbara Galli

  • The transcription factor E4bp4/Nfil3 controls commitment to the NK lineage and directly regulates Eomes and Id2 expression

    Victoria Male;Ilaria Nisoli;Tomasz Kostrzewski;David S.J. Allan

Frequent Co-Authors

Sergio Abrignani
Sergio Abrignani University of Milan
Derek O'hagan
Derek O'hagan GlaxoSmithKline (United Kingdom)
Anne O'Garra
Anne O'Garra The Francis Crick Institute
George Kassiotis
George Kassiotis The Francis Crick Institute
Rino Rappuoli
Rino Rappuoli Imperial College London
Charles Swanton
Charles Swanton The Francis Crick Institute
Giulia Casorati
Giulia Casorati Vita-Salute San Raffaele University
Dimitris Kioussis
Dimitris Kioussis Medical Research Council
Nicholas M. Valiante
Nicholas M. Valiante Novartis (Switzerland)
Ennio De Gregorio
Ennio De Gregorio Novartis (Switzerland)

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

For students interested in expanding their expertise beyond microbiology, several complementary online degrees offer excellent career opportunities. Programs like cahiim accredited health information management programs online provide vital training in managing patient data and health records, a growing field in healthcare.

Those looking for quicker credentialing may consider online medical billing and coding certificate fast programs. These certificates can jumpstart careers in administrative aspects of healthcare, complementing a microbiology background with knowledge of billing processes.

For broader clinical knowledge, exploring medical programs online can open doors to various health-related professions, including nursing and allied health fields, increasing versatility in career paths.

Additionally, pursuing a public health degree through the best easiest mph online programs to get into provides valuable insights into population health, epidemiology, and policy—areas closely tied to microbiology research and practice.

Best Scientists Citing Andreas Wack

Trending Scientists